Looking Back & Ahead
Just one year ago, we announced the partnership between ESMI and npj Imaging – a collaboration designed to promote scientific excellence and provide the imaging community with a dedicated publishing home for your research. One year on, it is the perfect time to look back & ahead and to share what we have achieved so far. We’d like to also extend a warm invitation to be part of this community effort – whether by contributing your research or joining the ESMI as an official member and enjoying the benefits of membership.
CONTENT
- Articles published
- (Future) JIF
- ESMI Collections
- Member Benefits
1. ARTICLES PUBLISHED
Since August 2025, 80 articles have been published in npj Imaging. Of these, 23 feature ESMI members as first or last authors (28.8%). To acknowledge this community effort and the trust of our members, please find all these articles below*. Overall, 636 authors have been involved in the publications – another wonderful sign of the breadth and interest of the imaging community.
2. (FUTURE) JIF
The principle: The Journal Impact Factor (JIF) reflects citations received in a given year by articles published in the previous two years, divided by the number of citable papers published during that period. npj Imaging is expected to receive its first Impact Factor in 2027. This will reflect citations received in 2026 for articles published in the previous two years.
“The journal is growing rapidly, the quality of the science is outstanding, and our early citation metrics are extremely encouraging. With our first Impact Factor on the horizon, this is a fantastic time to publish your best imaging science in our journal – you can really make a difference!” says Tim Witney, Editor-in-Chief
3. ESMI COLLECTION(S)
Our partnership includes an annual ESMI Collection curated by the society’s President. Edition #1 has been dedicated to IMAGING IMMUNE RESPONSES with 13 submissions so far: 2 accepted, 6 in peer review, and 5 rejected. Hurry to get your work featured – submissions close on 12 September 2026!
Edition #2 has just been launched and features an emerging topic: IMAGING OF AGEING AND RELATED DISEASES – a largely unexplored domain with tremendous potential to transform our understanding of the biological processes underlying ageing.
4. MEMBER BENEFITS – DID YOU KNOW?
A quick reminder that all ESMI members receive a 30% discount on Article Processing Charges, currently €2,390 – read about how this works here.
That’s our first year of partnership in a nutshell.
Thanks to all of you who have contributed to this success story so far – through publishing, reviewing, reading, and citing! And to everyone working in imaging science: we hope you will be part of the next chapter – whether by contributing your research or joining the ESMI – becoming part of the community behind it.
PUBLICATIONS by ESMI Members (first/last author) | sorted by publication date
September 2025
van der Bie J, Coleon A, Visser D, Bogers WM, den Dunnen J, Spronk HMH, Langermans JAM, Willemen HLDM, De Melo GD, Middeldorp J, Stammes MA. Post Pandemic Problem, is there an animal model suitable to investigate PASC. npj Imaging. 2025 Sep 15;3(1):41. doi: 10.1038/s44303-025-00101
Michiels L, Shameem M, Vanhoffelen E, Reséndiz-Sharpe A, Johnston SA, Beziere N, Vande Velde G. Fungal infections in focus: accelerating non-invasive imaging from preclinical insights to clinical breakthroughs. Npj Imaging. 2025 Sep 16;3(1):42. doi: 10.1038/s44303-025-00105-y.
Riberdy V, Guida A, Rioux J, Brewer K. Radiomics in preclinical imaging research: methods, challenges and opportunities. Npj Imaging. 2025 Sep 22;3(1):45. doi: 10.1038/s44303-025-00104-z.
October 2025
Gehmeyr M, Rojas López MB, Nitkunanantharajah S, Preißl H, Vosseler A, Schwartzenberg RJV, Birkenfeld AL, Katsouli N, Fasoula NA, Karlas A, Kallmayer M, Ziegler AG, Jüstel D, Ntziachristos V. Enhanced maximum intensity projection (eMIP) for improving the fidelity of optoacoustic images. Npj Imaging. 2025 Oct 6;3(1):49. doi: 10.1038/s44303-025-00112-z.
Sonay AY, Apfelbaum E, Larney BEM, Grimm J. Phosphatidylserine exposure and plasma membrane perforation as ferroptotic signatures for in vivo imaging. Npj Imaging. 2025 Oct 6;3(1):48. doi: 10.1038/s44303-025-00110-1.
November 2025
Volpe A, Pham J, Sellmyer MA, Ponomarev V. Practical considerations for clinical translation of PET imaging of adoptive cell therapies. Npj Imaging. 2025 Nov 24;3(1):59. doi: 10.1038/s44303-025-00127-6.
Keizers B, Stroet MCM, Ali M, Floru S, Saliën J, Mezzanotte L, Delikatny EJ, Gibbs SL, Giuliani S, Gioux S, Ingelberts H, Kruijff S, Ntziachristos V, LaRochelle E, Rogalla S, Rosenthal EL, Samkoe KS, Tichauer KM, Vahrmeijer AL, Witjes MJH, Voskuil FJ, Gorpas D, Hernot S, van der Zaag PJ. Reflect: reporting guidelines for preclinical, translational and clinical fluorescence molecular imaging studies. Npj Imaging. 2025 Nov 25;3(1):62. doi: 10.1038/s44303-025-00125-8.
Dvorakova Bendova K, Krasulova K, Neuzilova B, Hajduch M, Petrik M. New insights into radiolabelled siderophores for molecular imaging of bacterial infections. Npj Imaging. 2025 Nov 26;3(1):63. doi: 10.1038/s44303-025-00126-7.
January 2026
Philippe C, Cotton J, Bowden GD, Pöschel S, Knopf P, Schörg B, Gonzalez-Menendez I, Sonanini D, Flatz L, Allen-Auerbach M, Radu CG, Czernin J, Quintanilla-Martinez L, Hacker M, Pichler BJ, Maurer A, Kneilling M. Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapy. Npj Imaging. 2026 Jan 6;4(1):1. doi: 10.1038/s44303-025-00133-8.
Remlova E, Jessernig A, Bammel M, Nozdriukhin D, Chen Y, Cipolato O, Deán-Ben XL, Herrmann IK, Razansky D. Deep tissue optoacoustic monitoring of photothermal treatments in the NIR-II assisted with silica-coated gold nanorods. Npj Imaging. 2026 Jan 28;4(1):4. doi: 10.1038/s44303-025-00134-7.
February 2026
de Vries IJM. Imaging immune responses: visualizing immunity from molecules to medicine. Npj Imaging. 2026 Feb 2;4(1):6. doi: 10.1038/s44303-026-00137-y.
Herraiz A, Rodríguez-San-Pedro A, Casquero-Veiga M, Cossío U, Arias-Ramos N, Gutiérrez L, Romero-Sanz E, Luján-Rodríguez VM, Cerón C, Oteo M, González-Paredes A, López-Larrubia P, Rosales RTM, Cortes-Canteli M, Morcillo MA, Ruiz-Cabello J, Pellico J, Herranz F. A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator. Npj Imaging. 2026 Feb 10;4(1):8. doi: 10.1038/s44303-026-00142-1.
Neijenhuis LKA, Dijkhuis TH, Mandella MJ, Rubin SJS, Burggraaf J, Vahrmeijer AL, Rogalla S. Standardizing clinical trials in near-infrared fluorescence imaging: a workflow and regulatory framework proposal. Npj Imaging. 2026 Feb 20;4(1):10. doi: 10.1038/s44303-026-00139-w.
March 2026
Scodellaro R, Mietto M, Ferlini A, Alves F. Correlative multimodal imaging for microscale spatial mapping of collagen-gene activity interactions in human tissues. Npj Imaging. 2026 Mar 23;4(1):17. doi: 10.1038/s44303-026-00149-8.
Buvat I, Aarntzen E, Badawi RD, Ballesta A, Bock C, Chuah CN, Fisher J, Graff JP, Ilan Y, Isambert H, Ivanov PC, Izu LT, Koenen HJ, Langevin H, Lewis DY, Liem DA, Mackerodt J, Pires M, Sundar LK, Tawakol A, Ter Horst R, van Cranenbroek B, Weigelin B, Cherry SR, Beyer T. Cross-disciplinary methodologies for whole-person research – insights from EMPOWER2024. Npj Imaging. 2026 Mar 25;4(1):19. doi: 10.1038/s44303-026-00151-0.
April 2026
Gosse JT, Skelton CS, Tremblay ML, Wyatt H, Gonzalez V, Dawod B, Nuschke A, Davis C, Dirk B, Vila-Leahey A, Mackay A, Bobbitt K, West A, Vanderhyden B, Weir G, Merkx-Jacques A, Stanford M, Hrytsenko O, Brewer KD. MRI of combination immunotherapy in an epithelial ovarian cancer preclinical model. Npj Imaging. 2026 Apr 9;4(1):25. doi: 10.1038/s44303-026-00157-8.
May 2026
Caselitz L, Claßen M, Bühler A, Paulus LP, Grieshaber-Bouyer Mandelbaum H, Nedoschill E, Wölfle J, Hörning A, Knieling F, Regensburger AP, Wachter F. Non-invasive measurement of accelerated gastrointestinal transit in pediatric patients using Contrast-enhanced Multispectral optoacoustic tomography. Npj Imaging. 2026 May 4;4(1):32. doi: 10.1038/s44303-026-00169-4.
Dos Santos K, Calos SR, Dou Q, Takahashi AM, Tsai LL, Grant AK, Yen YF. Feasibility of co-polarizing ¹³C-pyruvate and ¹³C-tert-butanol for simultaneous metabolic and perfusion imaging. Npj Imaging. 2026 May 18;4(1):43. doi: 10.1038/s44303-026-00172-9.
Stowbur D, Mehling R, Knopf P, Schörg BF, Sonanini D, Arnold-Schild D, Gonzalez-Menendez I, Quintanilla-Martinez L, Fehrenbacher B, Schaller M, Carlsen H, Kumari S, Pichler BJ, Kneilling M. Noninvasive in vivo imaging of NF-κB activation predicts immunotherapy response in solid tumors. Npj Imaging. 2026 May 20;4(1):38. doi: 10.1038/s44303-026-00173-8.
McRae SW, Lau JH, Martinez FM, Zhao J, Fink C, Kelly JJ, Xia Y, Sanchez Pupo RE, Foster PJ, Scholl TJ, Ronald JA. Linking tumor viability and immune infiltration with dual-nucleus MRI in preclinical models. Npj Imaging. 2026 May 25;4(1):35. doi: 10.1038/s44303-026-00158-7.
July 2026
Aguirre J, Berezhnoi A, Hindelang B, Gasteiger C, He H, Darsow U, Biedermann T, Ntziachristos V. Recording skin oxygenation by dual-wavelength ultra-wideband optoacoustic mesoscopy. Npj Imaging. 2026 Jul 10;4(1):51. doi: 10.1038/s44303-026-00184-5.
Sehl OC, Fernando N, Kim P, Mohtasebzadeh AR, Sanders T, Guo K, Fellows B, Alvarado MD, Thierry B, Weyhmiller M, Greve JM, Lai SY, Goodwill PW, Foster PJ. Magnetic particle imaging tracers for human applications: preclinical in vivo evaluation of Magtrace, Resotran, and FerroTrace. Npj Imaging. 2026 Jul 21;4(1):48. doi: 10.1038/s44303-026-00182-7.
August 2026
Litvinenko, A., Koch, H., Corsanici, G. Battistini, G., Schottelius, M. Nuclear theranostics at a crossroads: from tracer optimization to biologically informed therapy. Npj Imaging 2026 doi.org/10.1038/s44303-026-00189-0
